ArticleBlood advances2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.
Jong Wook Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it